Hyaluronic Acid in CC
Hyaluronic Acid in CC section, includes general infrmation about Hyaluronic Acid Procedure, Hyaluronic Acid CC Local News, Hyaluronic Acid CC Surgeon Locator and other Hyaluronic Acid related material.
Hyaluronic Acid Procedure
Injectable fillers are one of the most popular facial rejuvenation techniques. As we age, the underlying tissues that keep our skin looking youthful and firm begin to break down due to the effects of gravity, sun exposure, diet, genetic factors, and years of facial muscle movement. Over time these factors contribute to the development of lines, wrinkles, and folds in the face.
Your skin consists of two layers known as the epidermis and the dermis. The epidermis, or outer layer of the skin, acts as the skin’s primary defense against the environment. The dermis, or innermost layer of the skin, is composed primarily of connective tissue and provides the skin with a support network. Most facial wrinkles and deeper folds occur within the dermal layer of the skin.
Within the connective tissue of the dermis, collagen and elastin fibers form a network that provides the skin with structure, support, and elasticity. Furthermore, fat cells and other molecules, such as hyaluronic acid, help to create volume beneath facial skin. With time, this network of collagen and elastin fibers breaks down, and hyaluronic acid molecules and fat cells that create volume are depleted. Together breakdown and depletion of these molecules result in wrinkles and other changes to facial skin.
When used as standalone treatments or with other procedures, injectable fillers can reduce or eliminate wrinkles and scars, create fuller lips, and treat lipoatrophy, or fat loss beneath the skin. With little downtime and almost immediate results, injectable fillers offer a safe, effective method of restoring a smoother, more youthful appearance.
Hyaluronic acid is a naturally occurring complex sugar molecule that forms large matrices in the connective tissue of the body, such as skin and cartilage. Much like a sponge, its primary function is to bind and absorb water molecules, which creates volume in the face. Hyaluronic acid fillers are generally used to treat facial wrinkles and folds and to enhance the appearance of the lips. One of the fastest growing dermal filler treatments available, hyaluronic acid fillers work by replacing the hyaluronic acid in the body that has depleted over time, which restores the volume beneath the skin’s surface.
While there are a variety of hyaluronic acid fillers, some of the most common are Hylaform®, Restylane®, and Juvederm®. Hylaform®, marketed by INAMED Aesthetics, consists of avian, or bird-derived, hyaluronic acid. Restylane®, marketed by Medicis, and Juvederm®, marketed by Allergan, are both non-animal derived forms of hyaluronic acid produced in the laboratory. Hyaluronic acid fillers are generally biocompatible, which means allergy skin testing is not required prior to treatment.
Depending on the extent of treatment, hyaluronic acid injection procedures typically last between fifteen and sixty minutes. Prior to the start of your procedure, the treatment areas will be cleansed, usually using an alcohol based cleaner. Unlike collagen injections, hyaluronic acid injections do not include an anesthetic agent. Therefore, a local or topical anesthetic may be used to numb the treatment area during the procedure.
Using an ultra fine needle, hyaluronic acid is injected into the dermis at several points along the edge of the treatment area. After approximately two to three injections, the physician will massage the treatment area. The physician will continue injecting the filler along the length of the wrinkle or fold until maximum correction has been achieved. If a local anesthesia has not been used, you may feel some minor stinging from the injections. As the injected hyaluronic acid molecules attract and bind water molecules, the volume beneath the skin will increase, restoring a smoother, more youthful appearance.
Immediately following the injections, you may experience some redness, slight stinging, minor swelling, or bruising in the treatment area. Tiny scabs may also form at the injection sites. These symptoms typically disappear within two to three days. No bandaging is necessary and most patients are able to resume normal activities immediately.
The body will eventually metabolize and absorb the injected hyaluronic acid over time. Therefore, while the effects are immediate, hyaluronic acid injections do not provide the same long-lasting results that may be gained from cosmetic surgery. Although the longevity of results varies by patient, results from hyaluronic acid injections are typically maintained for six to twelve months.
Other Hyaluronic Acid Procedures
All Skin Procedures
Hyaluronic Acid CC (current)
Hyaluronic Acid CC Chemical Peel
Hyaluronic Acid CC Dermabrasion
Hyaluronic Acid CC Laser Hair Removal
Hyaluronic Acid CC Collagen Injections
More CC info...
Caicos Islands Get out This article is an outline and needs more content. It has a template, but there is not enough information present. Please plunge forward and help it grow!
Caicos Islands Regions
Providenciales
North Caicos
Middle Caicos
East Caicos
South Caicos
West Caicos
Plastic Surgery News...
- Next week leading public service trade unionists from southern African nations will visit UNISON to draw up plans to help HIV/AIDS workers. The HIV/AIDS pandemic has a sharp Southern African focus - two thirds living with the disease globally are from the region. UNISON has secured £350,000 of government funding for the three year project, following an 18 month self funded initiative.
- The Canadian Agency for Drugs and Technologies in Health (CADTH) has published a systematic review and economic analysis (Canadian-based) on subcutaneous immunoglobulin (SCIg) and intravenous immunoglobulin (IVIg) for treatment of primary immunodeficiencies (PIDs). Although the use of IVIG for such indications is well established, SCIg is now available and offers a number of potential advantages. The authors therefore sought to compare the clinical and cost-effectiveness of these agents to inform public policy.
Systematic review of the literature yielded only one comparative randomised controlled trial; an additional eight comparative observational studies were located. The main findings were:
• On the limited evidence available, SCIg and IVIg appear to be similar in terms of most outcome measures
• Quality of life (QoL) was higher among SCIg patients.
• Hospital-based IVIg was associated with fewer quality-adjusted life-years (QALYs) than home-based IVIg or SCIg (0.648 versus 0.659 and 0.675 respectively) and higher associated costs (C$21,273 versus C$19,433 and C$20,065).
The authors conclude that “the comparison between IVIg and SCIg is based on limited clinical and economic information. SCIg may be considered as a reasonable alternative for patients with contraindications to IVIg and poor venous access. The widespread adoption of SCIg may be imprudent, until more information becomes available”.